Atara Biotherapeutics Statistics
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.93-0.4434 (-4.73%)
Market open · Delayed 15 min · as of Oct 8, 11:08 AM ET
Atara Biotherapeutics by the numbers
Atara Biotherapeutics has a market capitalization of $89.6 million based on 10.04M shares outstanding. With trailing EPS of $-1.30, Atara Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.5% below its 50-day average and 9.3% above its 200-day average.
Average daily trading volume is 54.11K shares, or about $483,036 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATRA valuation vs. peer median
| Metric | ATRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $89.60M | $87.88M | +2% |
| Avg. volume | 54.11K | 788.16K | -93% |
Peer median across 8 companies: NMRA, CGTX, BDTX, CRDF, PTHS, LENZ, GRML, ENGN.
Valuation
- Market cap
- $89.60M
- Forward P/E
- 5.78
- EPS (TTM)
- $-1.30
- Shares outstanding
- 10.04M
Price and trading
- Previous close
- 9.37
- Open
- 9.42
- Day range
- 8.82 – 9.42
- 52-week range
- 3.92 – 19.15
- 52-week change
- -40.05%
- Beta
- —
- Volume
- 6.68K
- Average volume
- 54.11K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 89.60M
- Forward Pe
- 5.78
- Eps
- -1.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.15
- Week52 Low
- 3.92
- Avg Volume
- 54,112.00
- Shares Outstanding
- 10.04M
- Ma50
- 9.07
- Ma200
- 8.17
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -53.37%
- Pct From52w Low
- 127.72%